<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30122853</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>17</Day>        </DateRevised>        <Article PubModel="Print">            <Journal>                <ISSN IssnType="Electronic">0975-1599</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>25</Volume>                    <Issue>2</Issue>                    <PubDate>                        <MedlineDate>2018 Apr-Jun</MedlineDate>                    </PubDate>                </JournalIssue>                <Title>Middle East African journal of ophthalmology</Title>                <ISOAbbreviation>Middle East Afr J Ophthalmol</ISOAbbreviation>            </Journal>            <ArticleTitle>Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.</ArticleTitle>            <Pagination>                <MedlinePgn>81-90</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.4103/meajo.MEAJO_6_18</ELocationID>            <Abstract>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of this study is to evaluate patients with uveal metastasis based on primary tumor site.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective analysis from Wills Eye Hospital, Philadelphia, PA, USA, for uveal metastasis clinical features and outcomes based on the primary tumor site.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 2214 uveal metastases diagnosed in 1111 consecutive patients. The demographics included mean age of 60 years (median 61 years), Caucasian race (88%), and female gender (64%). The tumor was unilateral (82%) and primary site was established before uveal metastasis (67%). The primary tumor originated in the breast (37%), lung (26%), kidney (4%), gastrointestinal (GI) tract (4%), cutaneous melanoma (2%), lung carcinoid (2%), prostate (2%), thyroid (1%), pancreas (1%), other sites (3%), and unknown (16%). Comparative analysis of the 5 most common primary sites (breast, lung, kidney, GI tract, and cutaneous melanoma), revealed metastasis at mean age (57, 62, 66, 61, 59 years), as unilateral tumor (74%, 86%, 85%, 93%, 85%), with mean number of metastasis/eye (1.9, 1.7, 1.0, 1.1, 2.0), and in females (99%, 46%, 26%, 25%, 30%). Choroidal metastases measured mean base (9.3, 10.2, 9.1, 11.0, 7.3 mm), mean thickness (2.4, 3.6, 4.4, 4.0, 2.9 mm), and demonstrated predominant color yellow (94%, 91%, 56%, 97%, 36%). Of the 769 patients with documented follow-up, mean patient survival was poor (22.2, 11.5, 8.6, 12.4, 11.4 months) and Kaplan-Meier analysis revealed 3-year survival (33%, 19%, 0%, 14%, 21%) and 5-year survival (24%, 13%, 0%, 14%, 21%). The worst survival was found in patients with pancreatic metastasis (mean 4.2 months) and best survival with lung carcinoid (92% at 5 years).</AbstractText>                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In a tertiary referral service, uveal metastasis originates from cancer in the breast, lung, kidney, GI tract, cutaneous melanoma, or others. Overall prognosis is poor with 5-year survival at 23% and worst survival with pancreatic metastasis whereas best survival with lung carcinoid metastasis.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Shields</LastName>                    <ForeName>Carol L</ForeName>                    <Initials>CL</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Welch</LastName>                    <ForeName>R Joel</ForeName>                    <Initials>RJ</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Malik</LastName>                    <ForeName>Kunal</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Acaba-Berrocal</LastName>                    <ForeName>Luis A</ForeName>                    <Initials>LA</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Selzer</LastName>                    <ForeName>Evan B</ForeName>                    <Initials>EB</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Newman</LastName>                    <ForeName>Jennifer H</ForeName>                    <Initials>JH</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mayro</LastName>                    <ForeName>Eileen L</ForeName>                    <Initials>EL</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Constantinescu</LastName>                    <ForeName>Alexandru B</ForeName>                    <Initials>AB</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Spencer</LastName>                    <ForeName>Meredith A</ForeName>                    <Initials>MA</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>McGarrey</LastName>                    <ForeName>Mark P</ForeName>                    <Initials>MP</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Knapp</LastName>                    <ForeName>Austen N</ForeName>                    <Initials>AN</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Graf</LastName>                    <ForeName>Alexander E</ForeName>                    <Initials>AE</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Altman</LastName>                    <ForeName>Alex J</ForeName>                    <Initials>AJ</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Considine</LastName>                    <ForeName>Sean P</ForeName>                    <Initials>SP</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shields</LastName>                    <ForeName>Jerry A</ForeName>                    <Initials>JA</Initials>                    <AffiliationInfo>                        <Affiliation>Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>        </Article>        <MedlineJournalInfo>            <Country>India</Country>            <MedlineTA>Middle East Afr J Ophthalmol</MedlineTA>            <NlmUniqueID>101521797</NlmUniqueID>            <ISSNLinking>0974-9233</ISSNLinking>        </MedlineJournalInfo>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):251-6</RefSource>                <PMID Version="1">9226310</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Ophthalmol. 1985 Jul;103(7):937-40</RefSource>                <PMID Version="1">4015484</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ophthalmology. 1979 Jul;86(7):1336-49</RefSource>                <PMID Version="1">233866</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Ophthalmol. 1997 Feb;115(2):203-9</RefSource>                <PMID Version="1">9046255</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 1997 Mar;15(3):1244-51</RefSource>                <PMID Version="1">9060569</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ophthalmology. 2011 Jul;118(7):1483-1483.e4</RefSource>                <PMID Version="1">21724049</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ophthalmology. 2012 Jun;119(6):1218-22</RefSource>                <PMID Version="1">22386261</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Ophthalmol. 1987 Sep;105(9):1215-9</RefSource>                <PMID Version="1">3307718</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ophthalmology. 2014 Jan;121(1):352-357</RefSource>                <PMID Version="1">23988200</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ophthalmologica. 2004 Nov-Dec;218(6):424-33</RefSource>                <PMID Version="1">15564763</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ophthalmology. 1997 Aug;104(8):1265-76</RefSource>                <PMID Version="1">9261313</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Ophthalmol. 1995 Apr;119(4):422-30</RefSource>                <PMID Version="1">7709967</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ophthalmology. 1994 Jun;101(6):1084-90</RefSource>                <PMID Version="1">8008351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Ophthalmol. 2003 Aug;136(2):264-71</RefSource>                <PMID Version="1">12888048</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Ophthalmol. 1974 Oct;92(4):276-86</RefSource>                <PMID Version="1">4412321</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Indian J Ophthalmol. 2015 Feb;63(2):122-7</RefSource>                <PMID Version="1">25827542</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cornea. 2015 Jan;34(1):42-8</RefSource>                <PMID Version="1">25343701</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Asia Pac J Ophthalmol (Phila). 2017 Mar-Apr;6(2):208-214</RefSource>                <PMID Version="1">28399345</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002829" MajorTopicYN="N">Choroid</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D002924" MajorTopicYN="N">Ciliary Body</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D003941" MajorTopicYN="Y">Diagnostic Techniques, Ophthalmological</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D007498" MajorTopicYN="N">Iris</DescriptorName>                <QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D009367" MajorTopicYN="Y">Neoplasm Staging</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D010414" MajorTopicYN="N">Pennsylvania</DescriptorName>                <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>                <QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D014604" MajorTopicYN="N">Uveal Neoplasms</DescriptorName>                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>                <QualifierName UI="Q000556" MajorTopicYN="Y">secondary</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">Choroid</Keyword>            <Keyword MajorTopicYN="N">ciliary body</Keyword>            <Keyword MajorTopicYN="N">eye</Keyword>            <Keyword MajorTopicYN="N">iris</Keyword>            <Keyword MajorTopicYN="N">metastasis</Keyword>            <Keyword MajorTopicYN="N">uvea</Keyword>        </KeywordList>        <CoiStatement>There are no conflicts of interest.</CoiStatement>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>21</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>18</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30122853</ArticleId>            <ArticleId IdType="doi">10.4103/meajo.MEAJO_6_18</ArticleId>            <ArticleId IdType="pii">MEAJO-25-81</ArticleId>            <ArticleId IdType="pmc">PMC6071342</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>